Although it has been suggested that decreased platelet imipramine bind
ing may be a putative biological marker of depressive illness, a numbe
r of studies have not confirmed this finding, including a recent multi
center investigation by the World Health Organization (Mellerup and La
nger 1990). We performed a meta-analysis of published reports on imipr
amine binding in groups of depressed and healthy control subjects and
found that there was a highly significant decrease in B-max (maximal b
inding) values in the depressed subject groups, which was even greater
among those who had been free of medication for 4 weeks at the rime o
f investigation. This finding remained highly significant even when on
ly high affinity binding studies (K-d < 1 nmol/L) were considered, alt
hough the absolute size of this decrease was smaller.